HPV9 vaccine, or Gardasil 9, to be added to national immunisation schedules from January 2027
Singapore will add the HPV9 vaccine to its national immunization schedules starting January 2027, providing broader protection against cervical cancer. The government will also introduce subsidies for eligible citizens and permanent residents to improve vaccine accessibility.
Why it matters
Expanding immunization coverage is a key public health strategy to reduce long-term cancer rates and healthcare costs.
The HPV9 vaccine, which offers broader protection against cervical cancer than HPV2, will be fully subsidised for eligible Singaporean children.
A box of Gardasil 9 human papillomavirus virus (HPV) vaccine. (File photo: AFP/Patrick T Fallon)
Emil Chan 02 Oct 2026 06:36PM (Updated: 03 Oct 2026 06:59AM) Bookmark Bookmark Share WhatsApp Telegram Facebook Twitter Email LinkedIn Set CNA as your preferred source on Google Add CNA as a trusted source to help Google better understand and surface our content in search results. Read a summary of this article on FAST. Get bite-sized news via a new cards interface. Give it a try. Click here to return to FAST Tap here to return to FAST FAST SINGAPORE: Gardasil 9, a human papillomavirus (HPV) vaccine that offers broader protection against cervical cancer, will be added to Singapore's national immunisation schedules from Jan 1, 2027.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in